You can also listen to the audio of this presentation here:
Comments
- No comments found
- Urine volume and change in estimated GFR
- Home
-
About ISN
- Membership
- News
- Topics
- Programs
- Regions
- Initiatives
- Publications
-
Education
-
Education Topics
- Pathology Topics
- Acute Kidney Injury
- Anemia, Iron and trace elements
- Chronic Kidney Disease
- Diabetes
- Fluid and Electrolytes
- General Nephrology
- Global Nephrology
- Glomerular Disease
- Hemodialysis
- Hypertension
- Infections
- Interventional Nephrology
- Mineral and bone disorders
- Nutrition and Hydration
- Peritoneal Dialysis
- Systemic Disease
- Transplantation
- Research Methodology
- Urolithiasis
- Basic Science
-
Education Topics
- Events
Monday, 25 April 2016 23:53
PEER: Insights for Improving Care in Kidney Disease Patients
By Kelly HendricksThis presentation was given by James Wetmore, Assoc. Professor of Medicine, Univ. of Minnesota Division of Nephrology at Hennepin Co. Medical Center. It was presented during the Renal Research Institute 18th International Conference on Dialysis, Advances in Kidney Disease held January 20-22, 2016 in Miami, Florida (USA).
Additional Info
- Language: English
- Contains Audio: Yes
- Content Type: Presentations
- Source: Other sources
- Event: Other events
- Year: 2016
- Members Only: No
Read 45 times
Published in
Chronic Kidney Disease
Tagged under
Latest from Kelly Hendricks
- Hemodynamic effects of sun exposure - what is the data, what is the relevance?
- AKI: Tubular Markers and Risk for CKD and ESRD
- Diet and CKD Progression: What are the Facts?
- Management of Patients with Diabetes and CKD: A perspective on new drugs & recommendations for BP targets
- Mineralocorticoid receptor antagonists in ESRD: Efficacy and Safety
Related items
- The Lancet Kidney Campaign puts the spotlight on kidney health policy
- Hemodynamic effects of sun exposure - what is the data, what is the relevance?
- AKI: Tubular Markers and Risk for CKD and ESRD
- Diet and CKD Progression: What are the Facts?
- Management of Patients with Diabetes and CKD: A perspective on new drugs & recommendations for BP targets
More in this category:
« Mineralocorticoid receptor antagonists in ESRD: Efficacy and Safety
|
Global Operations Center Rue des Fabriques 1 |
Americas Operations Center 340 North Avenue 3rd Floor |
ISN Membership Survey
If you are an ISN member, please take this survey to help us create a better society for you.
Click the image above to begin
Administrator Login
Leave your comments
Post comment as a guest